Over the past decade, Greece’s contraceptives market, focusing on hormones or spermicides, has seen a noticeable decline from 2013 through 2023, with a notable shift downward from $20.139 million in 2013 to $7.4036 million in 2023. The market faced an average annual contraction of 9.03% over the last five years, with particularly significant drops in 2021 and 2022.
Looking ahead, several trends could shape the future of the market:
- Increasing awareness and access to modern contraceptive methods.
- Potential regulatory changes impacting hormonal contraceptives.
- Growing demand for non-hormonal alternatives.
How does Greece rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 13 | 13 Slovenia | 14,356,000 | 2023 | -0.84% | -0.67% | View data |
| 14 | 14 Nicaragua | 12,896,000 | 2023 | +0.83% | +0.76% | View data |
| 15 | 15 Greece | 7,403,600 | 2023 | -12.99% | -9.03% | |
| 16 | 16 Bulgaria | 6,396,000 | 2023 | -0.93% | -0.79% | View data |
| 17 | 17 Moldova | 2,044,500 | 2023 | +0.81% | +2.57% | View data |
